banner

DTC Lifts Chill on Shares of Universal Bioenergy

On July 22, the Depository Trust Company, or DTC, imposed a “deposit chill” on shares of Universal Bioenergy Inc. (OTCQB: UBRG), an  independent diversified energy company that produces and markets natural gas, petroleum, coal and propane.

Universal Bioenergy (UBRG)

DTC, the largest securities depository in the world with 3.6 million securities worth $35 trillion on deposit, was created by the securities industry to improve efficiencies and reduce risk in the clearance and settlement of securities transactions.

A DTC chill can happen for a variety of reasons and entails a restriction of one type or another in DTC services.  It is unlike a “freeze” wherein all DTC services are discontinued until compliance is met or the security is completely removed from DTC listing.

In the case of Universal Bioenergy, the DTC requested that company demonstrate that the sale and transfer of certain shares of its common stock, were made pursuant to an effective registration statement under the Securities Act, or the shares did not require registration thereunder. Universal’s independent legal counsel provided full documentation to the DTC, to the effect that the shares were freely tradable without restriction under the securities laws, according to today’s corporate statement.



To that end, all DCT restrictions have been removed, the DTC is again accepting deposits of UBRG for book entry transfer services and the stock has resumed full electronic trading.  Generally speaking, this should improve liquidity in the stock, but the restriction did little to crimp daily trading volumes in the Irvine, California-based company.

“Although many had doubts, management made promises to use every effort to gain approval to remove the Chill, and we were successful,” said Solomon Ali, Universal’s Senior Vice President.

Shares of UBRG slipped during the DTC chill to lows of $0.0031 in mid-September, but rebounded to hit a high of 1.15 cents in the opening days of October before fading back into sub-penny range.  Today, shares are ahead by 25.49 percent halfway through the trading day; printing $0.006 on 1.7 million in volume.

Universal Bioenergy (UBRG) Stock Quote and News:







Disclaimer: Neither www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Prior compensation is listed in our full disclosure. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Hearing Date Set in Blue Calypso Lawsuit Against LivingSocial

Hearing Date Set in Blue Calypso Lawsuit Against LivingSocial(0)

Blue Calypso Inc. (OTCBB: BCYP), an innovator in digital social advertising, mobile content syndication, and analytics, recently announced a Markman hearing set for August 27, 2013 in its patent infringement case against LivingSocial. Findings from this hearing may encourage settlements or provide insight into the likelihood of a particular outcome. With the success seen by

Digital Development Group Partners with Hollywood Bad Boy Charlie Sheen

Digital Development Group Partners with Hollywood Bad Boy Charlie Sheen(0)

One might think that celebrity endorsements would be fantastic for the share price of a small or microcap company. After all, famous and successful athletes or movie stars have a stack of cash to invest and the connections to help accelerate business developments. Oddly, though, it doesn’t seem to have a great deal of impact.

Sunvalley Solar Shares Rise from Bottom on Solar Installation Contract

Sunvalley Solar Shares Rise from Bottom on Solar Installation Contract(0)

Shares of Sunvalley Solar, Inc. (OTCBB: SSOL) are rising in trading Monday morning after the solar power technology company disclosed a new contract to 87.5-kilowatt solar system installation contract from Corporate Logistics in City of Industry, California. The contract is for a system capable of generating 131,146 kilowatt hours of electrical power each year, utilizing

Men’s Health Features Naked Brand Group Line of Underwear

Men’s Health Features Naked Brand Group Line of Underwear(0)

Naked Brand Group, Inc. (OTCQB: NAKD) said Friday that its Naked Boxer Brief has been selected by Men’s Health for its online guide, “Affordable Spring Style Guide 100 under $100.”  The guide was published on MensHealth.com on March 20.  This is the second time the company has been featured in the men’s mag in as

Sunshine Biopharma Meeting with CMOs to Manufacture Drug for Breast Cancer Trials

Sunshine Biopharma Meeting with CMOs to Manufacture Drug for Breast Cancer Trials(0)

Sunshine Biopharma Inc. (OTCQB: SBFM) reported on Thursday that it is in negotiations with Contract Manufacturing Organizations, or CMOs, as the next progression towards the anticipated clinical trials of its flagship cancer drug, Adva-27a, against multi-drug resistant forms of breast cancer. The trials are scheduled to be hosted by the leading cancer center Jewish General

read more
banner


Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.